Cysteine Metabolism Crucial for Ferroptosis Regulation in Cancer

Ferroptosis is a form of non-apoptotic cell death that is critical for cancer therapy. Current research has shown that cysteine metabolism plays a pivotal role in ferroptosis regulation by modulating antioxidant defense, lipid peroxidation, and iron homeostasis. Cancer cells exploit cysteine availability to evade ferroptotic cell death, contributing to tumor progression and therapy resistance. A comprehensive understanding of cysteine metabolism is essential to develop effective cancer treatments.

Key Takeaways:

Cysteine metabolism is a critical regulator of ferroptosis, a form of non-apoptotic cell death that is essential for cancer therapy.
Cancer cells exploit cysteine availability to evade ferroptotic cell death, contributing to tumor progression and therapy resistance.
Systemic cysteine depletion, xCT inhibition, suppression of HS biosynthesis, and GPX4-targeted therapies are promising approaches to targeting cysteine metabolism in cancer.
Preclinical studies have demonstrated the efficacy of these approaches, but in vivo validation and clinical translation remain limited.
Advancing cysteine-targeting therapies require further mechanistic insights, biomarker identification, and optimized delivery strategies.
Researchers at CHA University have conducted a comprehensive review of cysteine metabolism and its roles in ferroptosis suppression.
The review discusses therapeutic strategies targeting cysteine metabolism, including systemic cysteine depletion, xCT inhibition, and GPX4-targeted therapies.

Statistics:

215:104906 is the journal article number for the research study.
2025 is the year of publication for the research study.
104906 is the journal article number for the research study.
CHA University is the institution conducting the research study.
Critical Reviews In Oncology Hematology is the journal title for the research study.

Sources:

Cysteine metabolism at the crossroads of ferroptosis and cancer therapy. Critical Reviews In Oncology Hematology, 2025;215:104906.
Critical Reviews In Oncology Hematology, 230 Park Ave, Ste 800, New York, NY 10169, USA.
Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA.
Jaewang Lee, Dept. of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.